Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: An arterial stiffness-related phenomenon - The Hoorn Study

被引:42
作者
Henry, RMA
Kamp, O
Kostense, PJ
Spijkerman, AMW
Dekker, JM
Nijpels, G
Heine, RJ
Bouter, LM
Stehouwer, CDA
机构
[1] Univ Hosp Maastricht, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands
[2] Vrije Univ Amsterdam, Ctr Med, Inst Res Extramural Med, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Ctr Med, Cardiovasc Res Inst, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Ctr Med, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Ctr Med, Dept Cardiol, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Ctr Med, Dept Endocrinol, Amsterdam, Netherlands
[7] Vrije Univ Amsterdam, Ctr Med, Dept Internal Med, Amsterdam, Netherlands
关键词
renal function; general population; risk factors; left ventricular hypertrophy;
D O I
10.1111/j.1523-1755.2005.00445.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Mild renal insufficiency has recently been recognized as an important risk factor for cardiovascular disease (CVD). The mechanisms underlying this association are incompletely understood. Increased left ventricular mass (LVM) is an independent risk factor for CVD, which is particularly common in end-stage renal disease ( ESRD) and which has been shown to be associated with mild renal insufficiency. Increased arterial stiffness has also been shown to be an independent risk factor for CVD in ESRD and has also been associated with mild renal insufficiency. We hypothesized that the association between mild renal insufficiency and increased LVM could be mediated through increased arterial stiffness, and that this may be one of the pathways linking mild renal insufficiency to CVD. We therefore investigated, in a cross-sectional population-based study, the influence of increased arterial stiffness on the association between renal function and LVM. Methods. The study population consisted of 742 elderly individuals ( 373 men and 369 women). Renal function was estimated by the serum creatinine level in mu mol/L; by the Cockcroft-Gault formula in mL/min and by the Modification of Diet in Renal Disease (MDRD) formula. LVM was obtained by echocardiography. Results. The mean estimates of renal function in men and women were, respectively, 103.7 (SD 17.0) and 86.8 (SD 11.2) mu mol/L for the serum creatinine level; 63.4 ( SD 12.9)and 61.4 ( SD 11.0) mL/min/ 1.73m(2) for the Cockcroft-Gault formula; and 59.7 ( SD 10.8) and 60.9 ( SD 10.5) mL/min per 1.73 m(2) for the MDRD formula. LVM was 93.1 ( SD 26.4) g/m(2) in men and 86.7 ( SD 22.3) g/m(2) in women. In men, impaired renal function, as estimated by the Cockcroft-Gault and the MDRD formula, was significantly associated with greater LVM after adjustment for age, glucose tolerance, hypertension, and prior CVD [ regression coefficient beta ( 95% CI), 1.28 ( 0.22 to 2.33) g/m(2) and 1.63 (0.41 to 2.86) g/m(2) per 5 mL/min/1.73m(2) decrease, respectively]. However, the association between impaired renal function and increased LVM was not statistically significant after adjustment for arterial stiffness estimates [regression coefficient b ( 95% CI), 0.02 (-1.60 to 1.64) g/m(2) and 0.54 (-1.25 to 2.33) g/m(2) per 5 mL/ min/1.73 m(2) decrease, respectively]. In women, impaired renal function was not significantly associated with greater LVM. Conclusion. Our study shows that in a general elderly population, even mild impairment of renal function is associated with adverse changes in left ventricular structure. In men, but not in women, this leads to greater LVM, a process that may be related to increases in arterial stiffness. Importantly, these novel findings suggest that such changes occur early in the process of renal functional deterioration, which may explain, in part, the increase in cardiovascular risk in men with mildly impaired renal function.
引用
收藏
页码:673 / 679
页数:7
相关论文
共 58 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness:: different effects in diabetic and non-diabetic individuals The Hoorn Study [J].
Becker, A ;
Henry, RMA ;
Kostense, PJ ;
Jakobs, C ;
Teerlink, T ;
Zweegman, S ;
Dekker, JM ;
Nijpels, G ;
Heine, RJ ;
Bouter, LM ;
Smulders, YM ;
Stehouwer, CDA .
ATHEROSCLEROSIS, 2003, 169 (02) :323-330
[4]   Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment:: the LIFE study [J].
Bella, JN ;
Palmieri, V ;
Wachtell, K ;
Liu, JE ;
Gerdts, E ;
Nieminen, MS ;
Koren, MJ ;
Zabalgoitia, M ;
Wright, JT ;
Dahlöf, B ;
Devereux, RB .
JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (06) :411-416
[5]   Why is left ventricular hypertrophy so predictive of morbidity and mortality? [J].
Benjamin, EJ ;
Levy, D .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 317 (03) :168-175
[6]   ASYMPTOMATIC VENTRICULAR ARRHYTHMIAS AND MORTALITY RISK IN SUBJECTS WITH LEFT-VENTRICULAR HYPERTROPHY [J].
BIKKINA, M ;
LARSON, MG ;
LEVY, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) :1111-1116
[7]   Impact of aortic stiffness on survival in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
Safar, ME ;
London, GM .
CIRCULATION, 1999, 99 (18) :2434-2439
[8]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[9]   Prognostic significance of arterial stiffness measurements in end-stage renal disease patients [J].
Blacher, J ;
Safar, ME ;
Pannier, B ;
Guerin, AP ;
Marchais, SJ ;
London, GM .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (06) :629-634
[10]   Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease [J].
Blacher, J ;
Pannier, B ;
Guerin, AP ;
Marchais, SJ ;
Safar, ME ;
London, GM .
HYPERTENSION, 1998, 32 (03) :570-574